Annals of Clinical Nutrition and Metabolism

Original Articles

Effects of nutritional status and support on the survival of COVID-19 patients in a single tertiary-center intensive care unit in Korea: a case-control study: Na Gyeong Lee, Hye Jin Kim, Ji Gyeong Kang, Do Hyeon Jeon, Mi Seung Kwak, So Hyun Nam; Ann Clin Nutr Metab 2023;15(1):30-37. Published online April 1, 2023; DOI: https://doi.org/10.15747/ACNM.2023.15.1.30

Purpose: It is important to understand the nutritional status of critically ill COVID-19 patients and to provide adequate associated support. We attempted to determine how nutritional status and the amount of nutritional support provided to critically ill patients affect their survival.
Methods: We retrospectively reviewed the medical records of patients admitted to the intensive care unit of Dong-A University Hospital between January and December 2021. We divided the patients into survivors and those who died during COVID-19 treatment and compared and analyzed their clinical parameters, nutrition-related indicators, nutritional status, and nutritional support.
Results: Of 70 patients reviewed, 57 survived. Mortality was higher in the older group (P=0.006). The patients who underwent ventilator, extracorporeal membrane oxygenation, or continuous renal replacement therapy showed higher mortality. Nutritional status at the time of admission and the nutritional requirements did not differ among patient groups. However, the actual amounts of calories (P<0.001) and protein (P=0.019) supplied were lower in the mortality group. Serum C-reactive protein level was higher (P=0.002) and serum albumin level was lower in those who did not survive (P<0.001) compared with surviving patients at discharge.
Conclusion: We did not determine whether the initial nutritional status of patients with COVID-19 affected their survival due to various factors associated with the severity of the disease. However, given the similarities between disease severity and nutritional status at the time of admission, our results indicate that adequate nutritional support can contribute to survival in critically ill COVID-19 patients with pneumonia.

Citations

Citations to this article as recorded by

The association between enteral nutrition with survival of critical patients with COVID‐19
Maryam Gholamalizadeh, Zahra Salimi, Khadijeh Abbasi Mobarakeh, Zahra Mahmoudi, Shirin Tajadod, Mahdi Mousavi Mele, Farkhondeh Alami, Bojlul Bahar, Saeid Doaei, Sara Khoshdooz, Masoume Rahvar, Somayeh Gholami, Masoume Pourtaleb
Immunity, Inflammation and Disease.2024;[Epub] CrossRef

262 View
2 Download
1 Crossref

Relationship of Sarcopenia with the Outcomes of Patients who Underwent Surgery for Bile Duct Cancer: Hye Jin Kim, Min-Su Park, Bum-Soo Kim, Sang-Mok Lee; Surg Metab Nutr 2019;10(2):54-58. Published online December 30, 2019; DOI: https://doi.org/10.18858/smn.2019.10.2.54

Abstract PDF ePub

Purpose:

This study investigated the impact of Sarcopenia by examining the psoas muscle on the outcomes after bile duct resection for bile duct cancer.

Materials and Methods:

This study retrospectively analyzed 101 patients who underwent surgery for bile duct cancer between January 2006 and December 2015 at Kyung-Hee University Hospital. Skeletal muscle mass was evaluated by performing preoperative computed tomography to define Sarcopenia. Patients were classified into two groups by the median value of the psoas muscle index (PMI).

Results:

The median value of the psoas muscle index in female patients was 463.9 mm²/m², and the median value of the psoas muscle index in males was 688.7 mm²/m². In the sarcopenia group, the 1, 3, and 5-year recurrence free survival rates were 74.5%, 52.9%, and 27.5%, respectively. On the other hand, in the non-sarcopenia group the 1, 3, and 5-year recurrence free survival rates were 50%, 34%, and 28%, respectively. In the sarcopenia group, the 1, 3, and 5-year overall survival rates were 84.3%, 54.9%, and 31.4%, respectively. In the non-sarcopenia group, 1, 3, and 5-year overall survival rates were 58%, 40%, and 32%, respectively. However, recurrence-free survival and overall survival were not correlated with sarcopenia (P=0.131, P=0.163).

Conclusion:

Sarcopenia using the psoas muscle index (PMI) has no impact on outcomes of bile duct cancer patients who underwent surgery. (Surg Metab Nutr 2019;10:-58)